Mutant p53 exploits enhancers to elevate immunosuppressive chemokine expression and impair immune checkpoint inhibitors in pancreatic cancer is a research paper published in Immunity (2025). On theSindex it has a DataRank of 0. It has been cited 25 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01-NS118929
National Institutes of Health
Grant: R01-CA208205
National Institutes of Health
Grant: R35-CA197743
National Institutes of Health
Grant: U01-CA261842
National Institutes of Health
Grant: U01-CA224348
National Institutes of Health
Grant: R01-CA259253
U.S. Public Health Service
Grant: R01-GM034277
National Foundation for Cancer Research
Grant: R00CA204595-05
NCI NIH HHS
Grant: U01 CA261842
NCI NIH HHS
Grant: R01 CA208205
NCI NIH HHS
Grant: R01 CA259253
NCI NIH HHS
Grant: R35 CA197743
NCI NIH HHS
Grant: P01 CA042063
NCI NIH HHS
Grant: U01 CA224348
NCI NIH HHS
Grant: R00 CA204595
NCI NIH HHS
Grant: R01 CA194535
NCI NIH HHS
Grant: R01 CA269672
NIGMS NIH HHS
Grant: R01 GM034277
NINDS NIH HHS
Grant: R01 NS118929
Japan Society for the Promotion of Science
Emerald Foundation
Ragon Institute of MGH, MIT and Harvard
GlaxoSmithKline
National Institutes of Health National Cancer Institute
Howard Hughes Medical Institute
Massachusetts General Hospital
Nile Albright Research Foundation
MeSH Terms
Keywords